-
Olfactory dysfunction in patient of Scans Without Evidence of Dopaminergic Deficit with parkinsonian bradykinesia
-
Olfactory Impairment in Parkinson’s Disease and White Matter Abnormalities in Central Olfactory Areas
-
ON-time evolution following one-year open-label opicapone: BIPARK-I study
-
Onabotulinumtoxin A (Botox) displays superior activity to incobotulinumtoxinA (Xeomin) in multiple in vitro and in vivo assays
-
Open label study of cannabidiol in Parkinson disease
-
Optimising STN-DBS frequency parameters for improvement of gait with dual tasking in PD patients
-
Optimization and evaluation of whole body MRI sequences for patients with deep brain stimulators
-
Optimization of Synucleinopathy and Nigrostriatal Degeneration Induced by Injection of Alpha-Synuclein Preformed Fibrils into Rat Striatum
-
Oral health-related quality of life and dental care among Parkinson’s disease patients and Care givers of South India.
-
Oromandibular dystonia (OMD): A Prospective, Single-Blind Trial of AbobotulinumtoxinA (AboA)
- « Previous Page
- 1
- …
- 100
- 101
- 102
- 103
- 104
- …
- 155
- Next Page »